According to IMARC Group latest report titled “Neurorehabilitation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on neurorehabilitation devices industry size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global neurorehabilitation devices market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.
Neurorehabilitation devices are tools that are widely utilized to help with neurological conditions, such as stroke, traumatic brain injury, spinal cord injury and cognitive functions. They range from simple tools that help with activities of daily living to more advanced, computer-based systems that use electrical stimulation to improve motor control and strength. They aid in diagnosing and treating a disease or injury in the patient’s nervous system and facilitate the re-learning of motor skills, including speech, language, and communication, and optimal recovery from neurological disorders. Additionally, they are extensively utilized among patients with neurological conditions to regain lost functions and improve their quality of life. Some of the commonly used devices include non-invasive brain stimulators, brain-computer interfaces, wearable devices, neurorobotic systems, and neuroproteins.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/neurorehabilitation-devices-market/requestsample
Market Trends:
Significant growth in the healthcare sector majorly drives the global market. This can be supported by the escalating number of clinics, research institutes, cognitive care, and healthcare centers due to the rising prevalence of neurological diseases, such as Parkinson’s disease, cerebral palsy, multiple sclerosis, and cardiovascular stroke. Along with this, the growing awareness and acceptance of the benefits of neurorehabilitation with accelerating research into the efficacy of neurorehabilitation devices significantly support the market. In addition, the rising demand for non-invasive treatments across the globe, as they are more cost-effective and less risky than traditional surgery, is also impacting the market favorably. Moreover, continual technological advancements, including the gamification of rehabilitation activities through robotics, artificial intelligence (AI), and virtual reality (VR), are creating a positive market outlook.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/neurorehabilitation-devices-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Biometrics Ltd, Bioness Inc.
- Bionik Laboratories Corp
- BioXtreme Ltd.
- Boston Scientific Corporation
- Ectron Ltd
- Ekso Bionics
- Hocoma AG (DIH International Limited)
- Kinestica
- Kinova Inc.
- Medtronic plc
- Saebo Inc
- Tyromotion GmbH
Neurorehabilitation Devices Market Segmentation:
Our report has categorized the market based on region, product type, application and end use.
Breakup by Product Type:
- Neurorobotic Devices
- Wearable Devices
- Non-Invasive Stimulators
- Brain-Computer Interface
Breakup by Application:
- Stroke
- Multiple Sclerosis
- Parkinson’s Disease
- Cerebral Palsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Cognitive Care Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800